| P50 | author | Diane Rosin | Q57436647 |
| | Mark D. Okusa | Q64163926 |
| | Li Li | Q64163976 |
| | Steven Song | Q88490092 |
| | Amandeep Bajwa | Q117256498 |
| P2093 | author name string | Hong Ye | |
| | Kevin R Lynch | |
| | Liping Huang | |
| | Peter I Lobo | |
| | Krishna Dondeti | |
| P2860 | cites work | Role of CD1d-restricted NKT cells in microbial immunity | Q24294851 |
| | Mechanisms for Glycolipid Antigen-Driven Cytokine Polarization by V 14i NKT Cells | Q27658388 |
| | NF-kappaB regulation in the immune system | Q28205043 |
| | Sphingosine 1-phosphate induces chemotaxis of immature and modulates cytokine-release in mature human dendritic cells for emergence of Th2 immune responses | Q28210836 |
| | The biology of NKT cells | Q28277482 |
| | Donor antigen-loaded IKK2dn gene-modified dendritic cells prolong allograft survival | Q28576467 |
| | Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation | Q28588671 |
| | Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration | Q28592508 |
| | An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow | Q29615498 |
| | Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells | Q30311230 |
| | Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemia-reperfusion injury | Q30432124 |
| | Macrophages, dendritic cells, and kidney ischemia-reperfusion injury | Q30432565 |
| | IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury | Q30437432 |
| | Divergent roles of sphingosine kinases in kidney ischemia-reperfusion injury | Q30439331 |
| | The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury | Q30439547 |
| | Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of CD4+ T cells and IFN-gamma | Q30439604 |
| | Sphingosine-1-phosphate receptors: biology and therapeutic potential in kidney disease | Q30440476 |
| | Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation | Q30442067 |
| | NKT cell activation mediates neutrophil IFN-gamma production and renal ischemia-reperfusion injury | Q30443445 |
| | Immunomodulator FTY720 Induces eNOS-dependent arterial vasodilatation via the lysophospholipid receptor S1P3. | Q33213454 |
| | CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney. | Q33246091 |
| | Renal dendritic cells ameliorate nephrotoxic acute kidney injury | Q33562179 |
| | S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species | Q33573630 |
| | Control of apoptosis by Rel/NF-kappaB transcription factors | Q33797163 |
| | Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells | Q33818603 |
| | Sphingosine 1-phosphate, a key cell signaling molecule | Q34128454 |
| | The Edg family G protein-coupled receptors for lysophospholipids: their signaling properties and biological activities | Q34662025 |
| | Apoptosis and inflammation in renal reperfusion injury | Q34708170 |
| | Sphingosine 1-phosphate as a therapeutic agent | Q34802499 |
| | Cellular pathophysiology of ischemic acute kidney injury | Q35484725 |
| | Dendritic cells: emerging pharmacological targets of immunosuppressive drugs | Q35620073 |
| | Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice | Q35698980 |
| | Inhibition of sphingosine 1-phosphate receptor 2 protects against renal ischemia-reperfusion injury | Q35715879 |
| | Toward an understanding of NKT cell biology: progress and paradoxes | Q36072480 |
| | Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells | Q36096376 |
| | Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure | Q36169286 |
| | Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network | Q36184401 |
| | Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein | Q36371349 |
| | The immune regulatory effect of apoptotic cells and exosomes on dendritic cells: its impact on transplantation | Q36373580 |
| | The sphingosine-1-phosphate (S1P) lysophospholipid receptor S1P3 regulates MAdCAM-1+ endothelial cells in splenic marginal sinus organization | Q36399632 |
| | CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution | Q36404242 |
| | Ischemia-reperfusion and immediate T cell responses | Q36973884 |
| | The alliance of sphingosine-1-phosphate and its receptors in immunity | Q37010807 |
| | Involvement of sphingosine 1-phosphate (SIP)/S1P3 signaling in cholestasis-induced liver fibrosis | Q37362062 |
| | Ischemia and reperfusion--from mechanism to translation | Q37455225 |
| | Hypoxia and inflammation | Q37842498 |
| | Mechanistic insights into achievement of cardiac allograft long-term survival by treatment with immature dendritic cells and sub-dose sirolimus | Q38315385 |
| | In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats | Q38344886 |
| | Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig | Q38363193 |
| | TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity | Q39738416 |
| | Hypoxia-inducible factor-dependent repression of equilibrative nucleoside transporter 2 attenuates mucosal inflammation during intestinal hypoxia | Q39902165 |
| | Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages | Q40488434 |
| | Lysosomal glycosphingolipid recognition by NKT cells | Q40493118 |
| | Activation of human Valpha24NKT cells by alpha-glycosylceramide in a CD1d-restricted and Valpha24TCR-mediated manner | Q40974453 |
| | Mouse CD1-specific NK1 T cells: development, specificity, and function | Q41464349 |
| | The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells | Q41815553 |
| | Selectivity and specificity of sphingosine-1-phosphate receptor ligands: caveats and critical thinking in characterizing receptor-mediated effects | Q42127017 |
| | Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity | Q42509581 |
| | Dendritic cell survival and maturation are regulated by different signaling pathways. | Q42971737 |
| | Effects of delayed rapamycin treatment on renal fibrosis and inflammation in experimental ischemia reperfusion injury | Q43224209 |
| | Recognition of bacterial glycosphingolipids by natural killer T cells | Q44582192 |
| | Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney | Q44916450 |
| | Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF-kappaB activity | Q45281233 |
| | Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis. | Q46034643 |
| | Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury | Q46503010 |
| | NKT cells: what's in a name? | Q47895830 |
| | Contrasting roles for STAT4 and STAT6 signal transduction pathways in murine renal ischemia-reperfusion injury | Q47958017 |
| | HIF-1alpha overexpression and experimental murine atherosclerosis. | Q51792819 |
| | Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation. | Q52578077 |
| | Application of recipient-derived dendritic cells to induce donor-specific T-cell hyporesponsiveness. | Q52965072 |
| | Renal ischemia-reperfusion injury: renal dendritic cells loudly sound the alarm. | Q53563325 |
| | Migration of CD4 T cells and dendritic cells toward sphingosine 1-phosphate (S1P) is mediated by different receptor subtypes: S1P regulates the functions of murine mature dendritic cells via S1P receptor type 3. | Q53567358 |
| | Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury. | Q53570210 |
| | Inhibition of nuclear factor κB by IκB superrepressor gene transfer ameliorates ischemia-reperfusion injury after experimental lung transplantation | Q59464727 |
| | The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice | Q63363340 |
| | Anti-CD45 monoclonal antibody perfusion of human renal allografts prior to transplantation. A safety and immunohistological study. CD45 Study Group | Q72266490 |
| | Analysis of mouse dendritic cell migration in vivo upon subcutaneous and intravenous injection | Q73128948 |
| | IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells | Q73365748 |
| | NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen | Q73586934 |
| | Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways | Q73850509 |
| | TCR V alpha 24 and V beta 11 coexpression defines a human NK1 T cell analog containing a unique Th0 subpopulation | Q74460187 |
| | Local expression of TNFalpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens | Q77658430 |
| | A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system | Q77929123 |
| | Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin | Q79309136 |
| | High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor | Q80284338 |
| | The role of dendritic cells in the development of acute dextran sulfate sodium colitis | Q81464370 |
| | A modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells | Q83220628 |
| | Use of the inhibitory effect of apoptotic cells on dendritic cells for graft survival via T-cell deletion and regulatory T cells | Q83314647 |
| | IL-6 and IL-8 release is mediated via multiple signaling pathways after stimulating dendritic cells with lysophospholipids | Q83977735 |
| | Invariant NKT cells producing IL-4 or IL-10, but not IFN-gamma, inhibit the Th1 response in experimental autoimmune encephalomyelitis, whereas none of these cells inhibits the Th17 response | Q84102344 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dendritic cell | Q506253 |
| | reperfusion injury | Q1413991 |
| P304 | page(s) | 2584-2596 | |
| P577 | publication date | 2012-08-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Dendritic cell sphingosine 1-phosphate receptor-3 regulates Th1-Th2 polarity in kidney ischemia-reperfusion injury | |
| P478 | volume | 189 | |